Mayinglong Pharmaceutical Group Co Ltd (600993) — Cash Flow-to-Debt Ratio
Mayinglong Pharmaceutical Group Co Ltd (600993) has a Cash Flow-to-Debt Ratio of 0.15x as of September 2025, meaning its operating cash flow of CN¥139.20 Million could theoretically repay 0% of its total liabilities (CN¥909.82 Million) in one year. Explore 600993 long-term investments to assets to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Mayinglong Pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Mayinglong Pharmaceutical Group Co Ltd across 23 annual periods. Also explore Mayinglong Pharmaceutical Group Co Ltd (600993) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Mayinglong Pharmaceutical Group Co Ltd (2003–2025)
Year-by-year debt coverage analysis for Mayinglong Pharmaceutical Group Co Ltd. For market capitalisation and broader financial context, see 600993 market cap.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.65x | CN¥600.44 Million | CN¥921.49 Million | ▲ +28.4% |
| 2024 | 0.51x | CN¥497.61 Million | CN¥980.66 Million | ▼ -19.4% |
| 2023 | 0.63x | CN¥604.07 Million | CN¥959.62 Million | ▲ +164.9% |
| 2022 | 0.24x | CN¥341.85 Million | CN¥1.44 Billion | ▼ -67.7% |
| 2021 | 0.73x | CN¥597.17 Million | CN¥812.72 Million | ▲ +138.9% |
| 2020 | 0.31x | CN¥282.99 Million | CN¥919.89 Million | ▼ -59.3% |
| 2019 | 0.76x | CN¥491.58 Million | CN¥650.49 Million | ▲ +40.9% |
| 2018 | 0.54x | CN¥308.24 Million | CN¥574.67 Million | ▼ -27.3% |
| 2017 | 0.74x | CN¥356.17 Million | CN¥482.99 Million | ▲ +47.7% |
| 2016 | 0.50x | CN¥239.60 Million | CN¥479.88 Million | ▲ +42.9% |
| 2015 | 0.35x | CN¥182.85 Million | CN¥523.31 Million | ▲ +52.3% |
| 2014 | 0.23x | CN¥111.67 Million | CN¥486.89 Million | ▼ -18.6% |
| 2013 | 0.28x | CN¥129.94 Million | CN¥461.22 Million | ▼ -31.8% |
| 2012 | 0.41x | CN¥169.25 Million | CN¥409.56 Million | ▲ +85.2% |
| 2011 | 0.22x | CN¥75.37 Million | CN¥337.70 Million | ▲ +728.6% |
| 2010 | -0.04x | CN¥-11.42 Million | CN¥321.68 Million | ▼ -106.3% |
| 2009 | 0.56x | CN¥216.11 Million | CN¥384.11 Million | ▲ +59.9% |
| 2008 | 0.35x | CN¥102.59 Million | CN¥291.46 Million | ▲ +1194.6% |
| 2007 | 0.03x | CN¥6.49 Million | CN¥238.53 Million | ▼ -91.0% |
| 2006 | 0.30x | CN¥75.27 Million | CN¥250.53 Million | ▼ -9.8% |
| 2005 | 0.33x | CN¥58.43 Million | CN¥175.45 Million | ▼ -19.6% |
| 2004 | 0.41x | CN¥54.19 Million | CN¥130.74 Million | ▼ -16.1% |
| 2003 | 0.49x | CN¥67.52 Million | CN¥136.61 Million | — |